Lipid-based nanocarrier-mediated targeted delivery of celecoxib attenuate severity of ulcerative colitis
Publication date: Available online 20 May 2020Source: Materials Science and Engineering: CAuthor(s): Rakesh Kumar Mishra, Anas Ahmad, Ajay Kumar, Akshay Vyawahare, Syed Shadab Raza, Rehan Khan
Source: Materials Science and Engineering: C - Category: Materials Science Source Type: research
More News: Celebrex | Inflammatory Bowel Disease | Materials Science | Nanotechnology | Science | Ulcerative Colitis